Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Ivan, Budnik"'
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 2, Iss 1 (2023)
Adenosine diphosphate (ADP) receptors and protein-kinase C (PKC) isoforms play different role in platelet activity. In the present study, whole blood platelet adhesion at 200 - 1800 s-1 shear rates was investigated by Impact-R system, measuring perce
Externí odkaz:
https://doaj.org/article/6f5ae9f9386c43cebd77c49603f8e5a1
Publikováno v:
International Journal of Ophthalmology, Vol 12, Iss 12, Pp 1872-1877 (2019)
AIM: To determine the rate and possible contributors for post-pars plana vitrectomy (PPV) epiretinal membrane (ERM) in patients treated for rhegmatogenous retinal detachment (RRD). METHODS: This prospective, nonrandomized study comprised 47 consecut
Externí odkaz:
https://doaj.org/article/75d52553cd2349ba90fd94ba2a85fd49
Publikováno v:
Platelets, Vol 29, Iss 3, Pp 265-269 (2018)
Mechanisms of platelet activation are triggered by thrombin, adenosine diphosphate (ADP), epinephrine, thromboxane A2, and other soluble agonists which induce signaling via heterotrimeric Gαq, Gαi, and Gα12/13 proteins. We have undertaken a study
Externí odkaz:
https://doaj.org/article/d055e24874ec42c487f0318c24e51313
Autor:
Omri Cohen, Nitsan Landau, Einat Avisahai, Tami Brutman-Barazani, Ivan Budnik, Tami Livnat, Keren Asraf, Ram Doolman, Sarina Levy-Mendelovich, Orly Efros, Uri Manor, Eyal Meltzer, Gad Segal, Galia Rahav, Gili Kenet
Publikováno v:
Acta Haematologica. 146:151-160
Introduction: Coronavirus disease 2019 (COVID-19) disease is associated with coagulopathy and an increased risk of thrombosis. An association between thrombin generation (TG) capacity, disease severity, and outcomes has not been well described. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91982eee904643b5333faab16f8f32c3
https://doi.org/10.1159/000527581
https://doi.org/10.1159/000527581
Autor:
Livnat, Yehonatan Weinberger, Ivan Budnik, Yael Nisgav, Dahlia Palevski, Gil Ben-David, José A. Fernández, Shany Nivinsky Margalit, Sarina Levy-Mendelovich, Gili Kenet, Dov Weinberger, John H. Griffin, Tami
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10642
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with cytoprotective properties and reduced bleeding risks. We studied the potential use of 3K3A-APC as a multi-target therapeutic option for choroidal neov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::5331e299299a66017693e8743c9aea03
Autor:
Tami Livnat, Yehonatan Weinberger, José A. Fernández, Alaa Bashir, Gil Ben-David, Dahlia Palevski, Sarina Levy-Mendelovich, Gili Kenet, Ivan Budnik, Yael Nisgav, John H. Griffin, Dov Weinberger
Publikováno v:
Biomolecules, Vol 11, Iss 3, p 358 (2021)
The activated protein C (APC) ability to inhibit choroidal neovascularization (CNV) growth and leakage was recently shown in a murine model. A modified APC, 3K3A-APC, was designed to reduce anticoagulant activity while maintaining full cytoprotective
Externí odkaz:
https://doaj.org/article/257408fbd8ea498eaece922f8cc88963
Autor:
Dahlia Palevski, Gil Ben-David, Yehonatan Weinberger, Rabeei Haj Daood, José A. Fernández, Ivan Budnik, Sarina Levy-Mendelovich, Gili Kenet, Yael Nisgav, Dov Weinberger, John H. Griffin, Tami Livnat
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14196
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with pleiotropic cytoprotective properties albeit without the bleeding risks. The anti-inflammatory activities of 3K3A-APC were demonstrated in multiple pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea6db775d2e61e32e5a17f35c92d9c5
https://pubmed.ncbi.nlm.nih.gov/36430674
https://pubmed.ncbi.nlm.nih.gov/36430674
Autor:
Assaf Arie Barg, Sarina Levy‐Mendelovich, Oded Gilad, Joanne Yacobovich, Ilia Tamarin, Ivan Budnik, Hana Golan, Amos Toren, Gili Kenet
Publikováno v:
Pediatric Blood & Cancer. 69
This is the first study examining real-life data of pediatric cancer patients treated with rivaroxaban. Children with thrombocytopenia and high bleeding risk were excluded from previous clinical trials. Data regarding the safety and efficacy of rivar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8cd79ca5c95c9f8c915c5f21e5699d3
https://doi.org/10.1002/pbc.29888
https://doi.org/10.1002/pbc.29888
Autor:
D. Bashari, Einat Avishai, Tami Brutman-Barazani, Tami Livnat, Gili Kenet, Amir A. Kuperman, Mudi Misgav, Ivan Budnik, Assaf A. Barg, Aaron Lubetsky
Publikováno v:
Haemophilia. 27:383-391
Introduction Real-world data on prophylaxis of severe haemophilia A (HA) patients treated by emicizumab are scarce. Aim To study the efficacy and safety of longitudinal emicizumab prophylaxis and assess laboratory monitoring correlations in a large p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac461d3d569b848101cd3e2d280a777a
https://doi.org/10.1111/hae.14318
https://doi.org/10.1111/hae.14318
Autor:
Yiftach Barbash, Daniella Levy-Erez, Eyal Klang, Ivan Budnik, Sarina Levy-Mendelovich, Raz Somech, Susan L. Furth, Shelly Soffer
Publikováno v:
Pediatric Research. 90:212-215
Background Pediatric research is a diverse field that is constantly growing. Current machine learning advancements have prompted a technique termed text-mining. In text-mining, information is extracted from texts using algorithms. This technique can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d6d6e820b0a98bc8623a0d5e2841777
https://doi.org/10.1038/s41390-021-01415-8
https://doi.org/10.1038/s41390-021-01415-8